CD8A and myeloid sarcoma: Collectively, our observations suggest that the MS-associated IL2RA SNP rs2104286 and the increased sIL-2Rα level associated with the risk rs2104286 genotype do not contribute to the CD8+ T cell response observed in MS and possibly abrogate it.